Abstract
We evaluated thyroid disease in 32 patients treated, during pre-puberty, for medulloblastoma, followed for at least 4 years and without relapse during observation. After surgery the patients underwent chemotherapy (CT) and radiotherapy (RT). The protocols were as follows: 20 patients (group A) SNC 76 and SNC 85 protocols which included conventional fractionated RT (36–40 Gy to the craniospinal axis and a 14–18 Gy boost to the posterior fossa, administered as 1.5–1.8 Gy per fraction per day) and a junction between the cranial and the spinal fields at C2–C3 level; 12 patients (group B) SNC 91 protocol which included hyperfractionated RT (36 Gy to the craniospinal axis and a 30 Gy boost to the posterior fossa; this was administred as 1 Gy per fraction twice per day) and a junction at levels C5–C6 or C6–C7 level. The mean age at diagnosis was 7.4±3.2 years for group A and 8.4±2.6 years for group B. Thyroid function was evaluated yearly and ultrasonographic characteristics every 2 years. The patients were followed for a mean of 10.8±3.8 for group A and 6±1.4 years for group B. Primary hypothyroidism was diagnosed in 16 group A patients and 4 group B patients, and central hypothyroidism was diagnosed in 2 group A patients (difference in risk of developing hypothyroidism evaluated with a Wilcoxon-test: p=0.048). Ultrasonography showed reduced thyroid volume in 7 group A cases, and structural changes in 21 patients (17 group A, 4 group B); 9 L-thyroxine-treated patients were confirmed hypothyroid after having stopped therapy. A thyroid nodule was detected in two cases (one from each group). In conclusion, our data indicate that thyroid injury may be diminished by the use of hyperfractionation and low-junction radiotherapy in the treatment of medulloblastoma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Shalet S.M. Disorder of the endocrine system due to radiation and cytotoxic chemiotheraphy. Clin. Endocrinol. (Oxf.) 1983, 18: 637–659.
Absusrewil S.S., Mott M., Oakhill G. Thyroid function in survivors of cancer. Arch. Dis. Child. 1989, 64: 709–712.
Livesey E.A., Brook C.G.D. Thyroid disfunction after radiotherapy and chemotherapy of brain tumours. Arch. Dis. Child. 1989, 64: 593–595.
Ogilvy-Stuart A.L., Shalet S.M. Thyroid function after treatment of brain tumors in children. J. Pediatr. 1991, 119: 733–737.
Oberfield S.E., Sklar C., Allen J., Walker R., McElwain M., Papadakis V., Maenza J., Ralston S., Levine S.L. Thyroid and gonadal function and growth of longterm survivors of medulloblastoma/PNET. In: Green D.M., D’Angio G.J. (Eds.), Late effects of treatment for childhood cancer. Wiley-Liss Inc., New York 1992, P. 55.
Chin D., Sklar C., Donahue B., Geneiser N., Allen J., Nirenberg A., David R., Kohn B., Oberfield S. Thyroid dysfunction as a late effect in survivors of pediatric medulloblastoma/primitive neuroectodermal tumors. Cancer 1997, 80: 798–804.
Pretorius H.T., Katikinemi M., Kinsella T.J. Thyroid nodules after high-dose external radiotherapy. JAMA 1980, 247: 3217–3220.
Straub W., Miller M., Sanislow C. Radiation and risk for thyroid cancer: atypical findings of a community thyroid recall program. Clin. Nucl. Med. 1982, 7: 272–276.
Cohen M.E., Duffner P.K. Medulloblastoma. In: Cohen M.E., Duffner P.K. (Eds.), Brain tumors in children: principles of diagnosis and treatment, ed. 2. Raven Press Ltd, New York, 1994, P. 177.
Danjou C.E., Jenkin R.D., Mc Laughlin J., Grimard L., Gaspar L.E., Dar A.R. Childhood medulloblastoma in Ontario, 1977–1987: population-based results. Med. Pediatr. Oncol. 1996, 26: 1–9.
Constine L.S. Woolf P.D. Cann D. Mick G. McCormick K., Raubertas R.F., Rubin P. Hypotalamic-pituitary disfunction after radiation for brain tumors. N. Engl. J. Med. 1993, 328: 87–94.
Littley M.D., Shalet S.M., Beardwell C.G. Radiation and hypothalamic-pituitary function. Baillieres Clin. Endocrinol. Metabol. 1990, 4: 147–175.
Shalet S.M. Radiation and pituitary dysfuntion. N. Engl. J. Med. 1993, 328: 131–133.
Ricardi U., Besenzon L., Cordero di Montezemolo L., Cenni M., Sandri S., Genitori L., Urgesi A. Low-dose hyperfractionated cranio-spinal radiation therapy for childhood cerebellar medulloblastoma: early results of a phase I–II study. Proceedings IX Congress ECCO, Hamburg (Germany) 1997, 911 (Abstract).
Narayana A., Jeswani S., Paulino A. The cranial-spinal junction in medulloblastoma: does it matter? Int. J. Radia. Oncol. Biol. Phys. 1999, 44: 81–84.
Nishiyama K., Tanaka E., Tarui Y., Miyauchi K., Okagawa K. A prospective analysis of subacute thyroid dysfunction after neck irradiation. Int. J. Radiat. Oncol. Biol. Phys. 1996, 34: 439–444.
Williams E.D. Biologic effects of radiation on the thyroid. In: Braverman L.E., Utiger R. (Eds.), Werner and Ingbar’s The Thyroid, ed. 6. J.B. Lippincott Company, New York, 1991, P. 421.
Rappaport R. Growth after cranial radiation and chemotherapy for tumors or leukemia. In: Bierich J.R., Cacciari E., Raiti S. (Eds.), Growth abnormalities. Raven Press Ltd, New York, 1989, P. 93.
Corrias A., Altare F., Besenzon L., Ricardi U., Andreo M., de Sanctis C. Difetti accrescitivi e disordini endocrini in pazienti radiotrattati per tumore cerebrale in età evolutiva. In: La Causa C., Seminara S., Bindi G. (Eds.), Problematiche attuali sulla diagnosi e terapia delle basse stature. Scientific Press, Firenze, 1997, P. 249.
Bantel J.P., Lee C.K., Levitte S. Thyrosine administration during radiation therapy to the neck does not prevent subsequent thyroid dysfunction. Int. J. Radiat. Oncol. Biol. Phys. 1985, 11: 1989–2002.
Lee K.O., Persani L., Tan M., Sundram F.X., Beck-Peccoz P. Thyrotropin with decreased biological activity, a delayed consequence of cranial irradiation for naso-pharyngeal carcinoma. J. Endocrinol. Invest. 1995, 18: 800–805.
Conrad R.A. Late radiation effects in Marshall Islanders exposed to fallout 28 years ago. In: Bojce J.D., Fraumeni J.F. (Eds.), Radiation carcino-genesis epidemiology and biological significance. Raven Press Ltd, New York, 1994, P. 57.
Ron E., Modan B., Preston D., Alfandary E., Stovall M., Boice J. Thyroid neoplasia following low-dose radiation in childhood. Radiat. Res. 1989, 120: 516–531.
Frankenthaler R.A., Sellin R.V., Cangir A., Goepfert H. Lymph node metastasis from papillary-follicular thyroid carcinoma in young patients. Am. J. Surg. 1990, 180: 341–343.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Corrias, A., Einaudi, S., Ricardi, U. et al. Thyroid diseases in patients treated during pre-puberty for medulloblastoma with different radiotherapic protocols. J Endocrinol Invest 24, 387–392 (2001). https://doi.org/10.1007/BF03351038
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03351038